Then, the authors discovered that miR-107 can directly bind to the 3′ untranslated region of the mRNA of the estrogen receptor in endometrioid carcinoma cells and inhibit the expression of α-estrogen receptors at the mRNA and protein levels in the cells. The gene discussed is ESR1; the disease is endometrioid adenocarcinoma.